Diversified Healthcare Trust Reports Q4 Earnings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 23 2026
0mins
Should l Buy DHC?
Source: seekingalpha
- Financial Performance: Diversified Healthcare Trust (DHC) reported a Q4 FFO of $0.09, aligning with market expectations, indicating the company's ability to maintain stable earnings amidst market fluctuations.
- Revenue Details: The company generated $379.57 million in revenue for Q4, showing no year-over-year growth but missing estimates by $13.32 million, reflecting increased market competition and operational challenges.
- Small-Cap Stock Dynamics: Within the small-cap sector, Diversified Healthcare Trust has a low dividend yield rating, which may diminish its appeal to investors, particularly those seeking stable income streams in a volatile market.
- Historical Data Insights: Historical earnings data for Diversified Healthcare Trust will serve as a crucial reference for future investment decisions, especially in the current economic climate where consistent performance is highly valued.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DHC
Wall Street analysts forecast DHC stock price to fall
3 Analyst Rating
1 Buy
1 Hold
1 Sell
Hold
Current: 7.270
Low
3.00
Averages
3.75
High
4.50
Current: 7.270
Low
3.00
Averages
3.75
High
4.50
About DHC
Diversified Healthcare Trust is a real estate investment trust (REIT). The Company is focused on owning healthcare properties located throughout the United States. It has an approximately $7.2 billion portfolio, which includes over 367 properties in 36 states and Washington, D.C., occupied by approximately 450 tenants, and totaling approximately 8.0 million square feet of life science and medical office properties and more than 27,000 senior living units. The Company's segments include Medical Office and Life Science Portfolio and SHOP. Its Medical Office and Life Science Portfolio segment primarily consists of medical office properties leased to medical providers and other medical-related businesses, as well as life science properties primarily leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Flat Footed LLC Fully Liquidates Matson Stake
- Stake Liquidation: Flat Footed LLC fully liquidated its 314,076-share stake in Matson during Q4 2026, resulting in a $30.96 million decrease in the position's quarter-end value, highlighting the impact of market fluctuations on its investment portfolio.
- Market Performance: As of February 17, 2026, Matson's shares were priced at $165.05, reflecting a 12.1% increase over the past year, outperforming the S&P 500 by 2.27 percentage points, indicating its relative strength in the shipping industry.
- Financial Overview: Matson's latest financial metrics reveal a TTM revenue of $3.34 billion and a net income of $444.8 million, with a dividend yield of 0.91%, suggesting a solid revenue stream and profitability.
- Industry Outlook: While global freight markets stabilize, Matson must focus on cargo demand in its domestic trade lanes and customers' willingness to pay for expedited shipping services to sustain profitability and competitive positioning.
See More
Flat Footed LLC Fully Liquidates Matson Stake
- Position Liquidation: Flat Footed LLC sold its entire stake of 314,076 shares in Matson during Q4, resulting in an estimated trade size of $30.96 million, which led to a 3.4% decrease in its reported AUM.
- Market Dynamics Impact: This transaction reflects not only the liquidation of Flat Footed LLC's holdings but also the impact of Matson's stock price fluctuations, resulting in a quarter-end position value of zero, down from 3.8% of the fund's AUM in the previous quarter.
- Industry Competitiveness: Matson, a leading provider of ocean transportation and logistics services, focuses on domestic U.S. trade lanes, particularly in Hawaii, Alaska, and Guam, benefiting from the protection of the Jones Act, which limits foreign competition.
- Future Outlook: While Matson benefited from strong trans-Pacific demand and premium pricing during the pandemic, its profitability will depend on continued cargo demand in domestic trade lanes and customers' willingness to pay for expedited shipping as global freight markets stabilize.
See More
BlackBarn Capital Increases Warby Parker Stake by 2 Million Shares
- Stake Increase: BlackBarn Capital increased its stake in Warby Parker by 2 million shares during Q4 2025, with an estimated transaction value of $43.52 million, indicating confidence in the company despite a 15% decline in its stock price over the past year.
- Value Appreciation: The value of Warby Parker's position rose by $37.79 million at quarter-end, reflecting the impact of trading activity and stock price fluctuations, suggesting that BlackBarn Capital's investment strategy is proving effective.
- Asset Allocation Shift: Following the increase, Warby Parker now accounts for 4.3% of BlackBarn Capital's 13F reportable assets, indicating its significance in the investment portfolio, even though it does not rank among the top five holdings.
- Market Performance Insight: As of February 13, 2026, Warby Parker shares were priced at $22.46, underperforming the S&P 500 by 26.8 percentage points, prompting investors to monitor the company's ability to achieve sustainable growth in the optical retail market.
See More
BlackBarn Capital Increases Warby Parker Stake to 3 Million Shares
- Share Increase: According to a recent SEC filing dated February 17, 2026, BlackBarn Capital Partners LP acquired an additional 2 million shares of Warby Parker, raising its total stake to 3 million shares, with an estimated transaction value of $43.52 million, reflecting confidence in the company's growth potential.
- Asset Management Proportion: Warby Parker now accounts for 4.3% of BlackBarn Capital's reportable assets under management, indicating its significance in the firm's 13F report and investor recognition of its potential value.
- Market Performance: As of February 13, 2026, Warby Parker shares were priced at $22.46, down 15% over the past year and underperforming the S&P 500 by 26.8 percentage points, highlighting market concerns regarding its future growth.
- Business Model Analysis: Warby Parker challenges traditional eyewear retail economics through a direct-to-consumer model, and while facing high costs and competitive pressures, its expanding exam capacity may ultimately be key to its future profitability.
See More
Diversified Healthcare Trust Q4 2025 Earnings Call Highlights
- Capital Markets Activity: DHC successfully executed capital markets activities in 2025, exceeding $1.4 billion in financing and asset sales while establishing a $150 million undrawn credit facility, significantly enhancing the company's financial flexibility and competitive position in the market.
- Strong Operational Performance: The company reported a 31.3% growth in SHOP NOI for 2025, with Q4 showing a year-over-year increase of 27.6% to $38.3 million, demonstrating robust operational efficiency and demand, solidifying its leading position in the U.S. REIT market.
- Asset Dispositions and Leverage Reduction: DHC disposed of 69 properties in 2025 for $605 million, successfully reducing the net debt to adjusted EBITDA ratio from 11.2x to 8.1x, thereby enhancing the company's financial health and stability.
- Positive Future Outlook: Management projects 2026 SHOP NOI to range from $175 million to $185 million and adjusted EBITDA to be between $290 million and $305 million, indicating strong growth potential driven by ongoing investments and operational improvements.
See More
Diversified Healthcare Reports Missed FFO Estimates
- Quarterly FFO Performance: Diversified Healthcare reported FFO of $0.09 per share, missing the Zacks consensus estimate of $0.12, indicating a 25% negative surprise that highlights pressure on the company's profitability.
- Revenue Situation: The company posted revenues of $379.57 million for the quarter, falling short of the Zacks consensus estimate by 4.53%, and nearly matching last year's $379.62 million, suggesting a lack of significant improvement in market demand.
- Market Performance: Although Diversified Healthcare's stock has risen about 28.7% since the beginning of the year, significantly outperforming the S&P 500's 0.9% gain, future stock movements will largely depend on management's commentary during the earnings call and FFO outlook.
- Industry Outlook: The REIT and Equity Trust - Other sector is currently ranked in the bottom 35% of Zacks industries, which could materially impact Diversified Healthcare's stock performance, prompting investors to monitor overall industry trends.
See More
Flat Footed LLC Fully Liquidates Matson Stake
- Stake Liquidation: Flat Footed LLC fully liquidated its 314,076-share stake in Matson during Q4 2026, resulting in a $30.96 million decrease in the position's quarter-end value, highlighting the impact of market fluctuations on its investment portfolio.
- Market Performance: As of February 17, 2026, Matson's shares were priced at $165.05, reflecting a 12.1% increase over the past year, outperforming the S&P 500 by 2.27 percentage points, indicating its relative strength in the shipping industry.
- Financial Overview: Matson's latest financial metrics reveal a TTM revenue of $3.34 billion and a net income of $444.8 million, with a dividend yield of 0.91%, suggesting a solid revenue stream and profitability.
- Industry Outlook: While global freight markets stabilize, Matson must focus on cargo demand in its domestic trade lanes and customers' willingness to pay for expedited shipping services to sustain profitability and competitive positioning.
See More
Flat Footed LLC Fully Liquidates Matson Stake
- Position Liquidation: Flat Footed LLC sold its entire stake of 314,076 shares in Matson during Q4, resulting in an estimated trade size of $30.96 million, which led to a 3.4% decrease in its reported AUM.
- Market Dynamics Impact: This transaction reflects not only the liquidation of Flat Footed LLC's holdings but also the impact of Matson's stock price fluctuations, resulting in a quarter-end position value of zero, down from 3.8% of the fund's AUM in the previous quarter.
- Industry Competitiveness: Matson, a leading provider of ocean transportation and logistics services, focuses on domestic U.S. trade lanes, particularly in Hawaii, Alaska, and Guam, benefiting from the protection of the Jones Act, which limits foreign competition.
- Future Outlook: While Matson benefited from strong trans-Pacific demand and premium pricing during the pandemic, its profitability will depend on continued cargo demand in domestic trade lanes and customers' willingness to pay for expedited shipping as global freight markets stabilize.
See More
BlackBarn Capital Increases Warby Parker Stake by 2 Million Shares
- Stake Increase: BlackBarn Capital increased its stake in Warby Parker by 2 million shares during Q4 2025, with an estimated transaction value of $43.52 million, indicating confidence in the company despite a 15% decline in its stock price over the past year.
- Value Appreciation: The value of Warby Parker's position rose by $37.79 million at quarter-end, reflecting the impact of trading activity and stock price fluctuations, suggesting that BlackBarn Capital's investment strategy is proving effective.
- Asset Allocation Shift: Following the increase, Warby Parker now accounts for 4.3% of BlackBarn Capital's 13F reportable assets, indicating its significance in the investment portfolio, even though it does not rank among the top five holdings.
- Market Performance Insight: As of February 13, 2026, Warby Parker shares were priced at $22.46, underperforming the S&P 500 by 26.8 percentage points, prompting investors to monitor the company's ability to achieve sustainable growth in the optical retail market.
See More
BlackBarn Capital Increases Warby Parker Stake to 3 Million Shares
- Share Increase: According to a recent SEC filing dated February 17, 2026, BlackBarn Capital Partners LP acquired an additional 2 million shares of Warby Parker, raising its total stake to 3 million shares, with an estimated transaction value of $43.52 million, reflecting confidence in the company's growth potential.
- Asset Management Proportion: Warby Parker now accounts for 4.3% of BlackBarn Capital's reportable assets under management, indicating its significance in the firm's 13F report and investor recognition of its potential value.
- Market Performance: As of February 13, 2026, Warby Parker shares were priced at $22.46, down 15% over the past year and underperforming the S&P 500 by 26.8 percentage points, highlighting market concerns regarding its future growth.
- Business Model Analysis: Warby Parker challenges traditional eyewear retail economics through a direct-to-consumer model, and while facing high costs and competitive pressures, its expanding exam capacity may ultimately be key to its future profitability.
See More
Diversified Healthcare Trust Q4 2025 Earnings Call Highlights
- Capital Markets Activity: DHC successfully executed capital markets activities in 2025, exceeding $1.4 billion in financing and asset sales while establishing a $150 million undrawn credit facility, significantly enhancing the company's financial flexibility and competitive position in the market.
- Strong Operational Performance: The company reported a 31.3% growth in SHOP NOI for 2025, with Q4 showing a year-over-year increase of 27.6% to $38.3 million, demonstrating robust operational efficiency and demand, solidifying its leading position in the U.S. REIT market.
- Asset Dispositions and Leverage Reduction: DHC disposed of 69 properties in 2025 for $605 million, successfully reducing the net debt to adjusted EBITDA ratio from 11.2x to 8.1x, thereby enhancing the company's financial health and stability.
- Positive Future Outlook: Management projects 2026 SHOP NOI to range from $175 million to $185 million and adjusted EBITDA to be between $290 million and $305 million, indicating strong growth potential driven by ongoing investments and operational improvements.
See More
Diversified Healthcare Reports Missed FFO Estimates
- Quarterly FFO Performance: Diversified Healthcare reported FFO of $0.09 per share, missing the Zacks consensus estimate of $0.12, indicating a 25% negative surprise that highlights pressure on the company's profitability.
- Revenue Situation: The company posted revenues of $379.57 million for the quarter, falling short of the Zacks consensus estimate by 4.53%, and nearly matching last year's $379.62 million, suggesting a lack of significant improvement in market demand.
- Market Performance: Although Diversified Healthcare's stock has risen about 28.7% since the beginning of the year, significantly outperforming the S&P 500's 0.9% gain, future stock movements will largely depend on management's commentary during the earnings call and FFO outlook.
- Industry Outlook: The REIT and Equity Trust - Other sector is currently ranked in the bottom 35% of Zacks industries, which could materially impact Diversified Healthcare's stock performance, prompting investors to monitor overall industry trends.
See More
